Back to top
more

IDEXX Laboratories (IDXX)

(Real Time Quote from BATS)

$420.57 USD

420.57
364,788

-3.08 (-0.73%)

Updated Nov 15, 2024 03:12 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 26% (65 out of 250)

Industry: Medical - Instruments

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Why You Should Retain Veeva (VEEV) in Your Portfolio Now?

by Zacks Equity Research

Investor confidence/optimism is high on Veeva (VEEV) stock, driven by its solid prospects.

Here's Why You Should Hold on to NuVasive (NUVA) Stock for Now

by Zacks Equity Research

Investors are optimistic about NuVasive (NUVA) on continued momentum across several recently launched products as well as potential in its U.S. Surgical Support business.

Here's Why You Should Add DaVita (DVA) to Your Portfolio Now

by Zacks Equity Research

Investor confidence is high on DaVita (DVA) stock, driven by its solid prospects.

Here's Why You Should Hold on to Illumina (ILMN) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about Illumina (ILMN), backed by its focus on partnerships and worldwide expansion to drive growth.

Integra (IART) Hits New 52-Week High: What's Driving It?

by Zacks Equity Research

Integra (IART) is optimistic about maintaining a robust product portfolio amid the pandemic-led business disruptions.

Here's Why You Should Hold on to ResMed (RMD) Stock for Now

by Zacks Equity Research

Investors continue to be optimistic about ResMed (RMD) owing to its potential in digital health and consistent high demand for its critical care products.

Urmimala Biswas headshot

5 Soaring MedTech Stocks to Buy for More Growth in 2021

by Urmimala Biswas

We have selected five MedTech growth stocks with further rooms for improvement in 2021.

Teleflex (TFX) Completes Buyout of Hemostatic Goods Producer

by Zacks Equity Research

Teleflex (TFX) to leverage its strength in enhancing clinical efficacy and patient safety via the recent buyout.

Here's Why You Must Add Accuray (ARAY) to Your Portfolio Now

by Zacks Equity Research

Investor confidence is high on Accuray (ARAY) stock, courtesy of its solid prospects.

Sanghamitra Saha headshot

10 Top-Performing Stocks of the S&P 500 ETF in 2020

by Sanghamitra Saha

If a Santa Claus rally grips Wall Street in the final days of December, the S&P 500 could see smart gains in 2020 despite the COVID-19 outbreak. These stocks helped the index to hit highs this year.

Why You Must Add Merit Medical (MMSI) Stock to Your Portfolio

by Zacks Equity Research

Investor optimism is high on Merit Medical (MMSI) stock, courtesy of solid prospects.

Here's Why You Should Retain Allscripts (MDRX) Stock for Now

by Zacks Equity Research

Investor confidence is high on Allscripts (MDRX) stock on the back of its solid prospects.

    Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (IDXX) Outperforming Other Medical Stocks This Year?

    IDEXX (IDXX) Gains on CAG Sales, Global Growth Remains Robust

    by Zacks Equity Research

    IDEXX (IDXX) sees sturdy gains in CAG Diagnostics recurring revenues, supported by high organic gains in both U.S. and International markets.

    4 Large Cap MedTech Stocks to Keep Winning Streaks Alive in 2021

    by Zacks Equity Research

    Four large-cap MedTech stocks are currently flourishing on the back of several positive developments

    Debanjana Dey headshot

    5 MedTech Stocks That Have Outperformed the Industry in 2020

    by Debanjana Dey

    Here are a few MedTech stocks which continued to outperform their respective industries amid the pandemic and can turn out to be wise investment choices.

    The Zacks Analyst Blog Highlights: L Brands, The Trade Desk, IDEXX Laboratories, NVIDIA and CrowdStrike

    by Zacks Equity Research

    The Zacks Analyst Blog Highlights: L Brands, The Trade Desk, IDEXX Laboratories, NVIDIA and CrowdStrike

    3 Reasons Why Idexx (IDXX) Is a Great Growth Stock

    by Zacks Equity Research

    Idexx (IDXX) is well positioned to outperform the market, as it exhibits above-average growth in financials.

    Top Ranked Growth Stocks to Buy for December 14th

    by Zacks Equity Research

    Here are three stocks with buy ranks and strong growth characteristics for investors to consider today, December 14th.

    Aniruddha Ganguly headshot

    Stimulus or No Stimulus, These Large Caps Are Must Buys

    by Aniruddha Ganguly

    Here we pick five large cap stocks -- LB, TTD, IDXX, NVDA & CRWD -- that are well-poised to grow on solid fundamentals and gradual economic recovery.

    KalVista Pharmaceuticals (KALV) Catches Eye: Stock Jumps 7.4%

    by Zacks Equity Research

    KalVista Pharmaceuticals (KALV) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.

    The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific

    by Zacks Equity Research

    The Zacks Analyst Blog Highlights: Quest Diagnostics, Laboratory Corporation of America, Hologic, IDEXX Laboratories and Thermo Fisher Scientific

    Is IDEXX Laboratories (IDXX) Outperforming Other Medical Stocks This Year?

    by Zacks Equity Research

    Is (IDXX) Outperforming Other Medical Stocks This Year?

    Urmimala Biswas headshot

    3 Growth Stocks to Tap the COVID-Driven Shift in MedTech

    by Urmimala Biswas

    To beat the pandemic blues and maximize capital gains, investors can now scoop up these fundamentally-strong MedTech growth stocks.

    Why IDEXX Laboratories (IDXX) Could Be an Impressive Growth Stock

    by Zacks Equity Research

    If you are looking for a fast-growing stock that is still seeing plenty of opportunities on the horizon, make sure to consider IDEXX Laboratories (IDXX).